Eno-Abasi Inyang, PharmD, BCPS, BCOP

Articles

Monitoring and Follow-Up of Patients with Chronic GVHD

September 25th 2023

The panel closes by reviewing the patient case once more and shares clinical pearls on the treatment of patients with GVHD.

Selecting Therapy for Steroid-Refractory Chronic GVHD

September 18th 2023

Dr Gooptu highlights how she selects therapy for a patient who is refractory to steroids for chronic GVHD and Dr Inyang notes the adverse events seen with these therapies.

The Steroid-Refractory Chronic GVHD Landscape

September 18th 2023

GVHD experts outline the treatment options for patients with steroid-refractory chronic GVHD.

Steroid Administration for Chronic GVHD

September 11th 2023

Details of steroid use for chronic GVHD, including taper and response criteria, are described by the panel.

Frontline Treatment of Chronic GVHD

September 11th 2023

The panel provides an overview of the frontline treatments available for chronic GVHD.

Challenges with Early Diagnosis of GVHD

September 4th 2023

Mahasweta Gooptu, MD shares insights on the early identification and diagnosis of chronic GVHD.

Chronic GVHD Incidence and Risk Factors

September 4th 2023

Dr Gooptu discusses the incidence of chronic GVHD and ruminates on how a patient’s medical history may impact their chronic GVHD risk.

Clinical Scenario: Chronic Graft Versus Host Disease

August 28th 2023

Signs and symptoms of chronic GVHD are explained through the lens of the clinical scenario.

Education and Resources for Patients with GVHD

August 28th 2023

The panel highlights the importance of a multidisciplinary approach and best practices in education for patients with GVHD.

Frontline Steroid Treatment for Acute GVHD

August 21st 2023

Drs Gootpu and Inyang explain use of corticosteroids as frontline treatment for acute GHVD.

Assessment and Grading of Acute GVHD

August 21st 2023

Dr Gooptu shares guidance on the assessment and grading of acute GVHD.

Acute GVHD Presentation and Diagnosis

August 14th 2023

Acute GVHD presentation and diagnosis is assessed for the clinical scenario previously discussed.

The GVHD Prophylaxis Landscape

August 14th 2023

GVHD prophylaxis techniques are analyzed by the panelists.

Risk Factors for Acute and Chronic GVHD

August 7th 2023

Dr. Gooptu explains the risk factors associated with both acute and chronic GVHD.

Conditioning Regimens for Stem Cell Transplantation

August 7th 2023

Eno-Abasi Inyang, PharmD, BCPS, BCOP provides an overview of the various conditioning regimens employed for allogeneic stem cell transplantation.

GVHD Incidence and Pathophysiology

July 31st 2023

Mahasweta Gooptu, MD, reviews statistics on graft versus host disease and explains the desired graft versus leukemia effect.

Clinical Scenario: A 38-Year-Old Man with Ph+ ALL

July 31st 2023

Bonnie Dirr, APRN, introduces a clinical scenario of a patient who received an allogeneic stem cell transplant from a sibling donor to begin the panel’s discussion of graft versus host disease.